Walleye Capital
Overview
Walleye Capital is a global multi-strategy investment firm that utilizes deep fundamental research, quantitative methods, and artificial intelligence. The firm's investment strategies cover Volatility, Fundamental Equities, Quant, and Tactical approaches.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Aardark Therapeutics | May 2024 | Series C | - |
| Odyssey Therapeutics | Dec 2023 | Series C | Co-investor |
| Clear Street | Apr 2023 | Series B Extension | Co-investor |
| Gauzy | Mar 2023 | Convertible Debt | Co-investor |
| Odyssey Therapeutics | Oct 2022 | Series B | Co-investor |
Key People
James Rowe
Managing Director
Richard Nathan Kalich
Managing Director
Jonathan Brenner
Partner, Chief Strategy Officer
Alberto M. Cozzini
Portfolio Manager
Alex Rubino
Portfolio Manager
Alex Tang
Quant Portfolio Manager
Allen C.
Portfolio Manager
Andrew Kim
Portfolio Manager
Andrew Sklar
Portfolio Manager
Benjamin Iriarte
Portfolio Manager, Quant Strategies
Bryan Wren
Portfolio Manager
Chao Lu
Portfolio Manager
Charles Taylor
Portfolio Manager
Curtis Kuznecov
Portfolio Manager
Daniel Gershenson
Portfolio Manager
Daniel Ioffe
Portfolio Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
